Cefodizime Sodium ≥96% (HPLC); CAS Number: ; Synonym: 5-Thia azabicyclo[]octenecarboxylic acid. Cefodizime Sodium is a medicine available in a number of countries worldwide. A list of US medications equivalent to Cefodizime Sodium is available on the. The first dose of cefodizime in patients with impaired renal function is the . The sodium content of cefodizime (75 mg/g) should be taken into.

Author: Zujin Kenris
Country: Tanzania
Language: English (Spanish)
Genre: History
Published (Last): 25 November 2016
Pages: 470
PDF File Size: 15.21 Mb
ePub File Size: 20.60 Mb
ISBN: 905-9-82413-613-8
Downloads: 68975
Price: Free* [*Free Regsitration Required]
Uploader: Kazishura

Testosterone cypionate Cefotaxime may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level. Sulfasalazine The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Sulfasalazine.

Rosiglitazone Cefotaxime may decrease the excretion rate of Rosiglitazone which could result in a higher serum level. Delorazepam The therapeutic efficacy of Delorazepam can be decreased when used in combination with Cefotaxime. Mycophenolate mofetil Cefotaxime may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.

Brinase The therapeutic efficacy of Brinase can be decreased when used in combination with Cefotaxime.

Cefotaxime – DrugBank

Tamsulosin Cefotaxime may decrease the excretion rate of Tamsulosin which could result in a higher serum level. Colchicine Cefotaxime may decrease the excretion ceffodizime of Colchicine which could result in a higher serum level. Tasimelteon Cefotaxime may decrease the excretion rate of Tasimelteon which could result in a higher serum level. Amlodipine Cefotaxime may decrease the excretion rate of Amlodipine which could result in a higher serum level.

Sodlum Cefotaxime may decrease the excretion rate of Pholcodine which could result in a higher serum level. Ioflupane I Cefotaxime may decrease the excretion rate of Ioflupane I which could result in a higher serum level.

Fluvoxamine Cefotaxime may decrease the excretion rate of Fluvoxamine which could result in a higher serum level. Etafedrine Cefotaxime may decrease the excretion rate of Etafedrine which could result in a higher serum level. Dimethyl sulfoxide Cefotaxime may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.

  GOD NO PENN JILLETTE PDF

Cefodizime

Phenelzine Cefotaxime may decrease the excretion rate of Phenelzine which could result in a higher serum level. Edetate disodium anhydrous The cefodixime efficacy of Edetate disodium anhydrous can be decreased when used in combination with Cefotaxime.

Tenoxicam The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Cefotaxime. Canagliflozin Cefotaxime may decrease the excretion rate of Ceffodizime which could result in a higher serum level. Cefcapene The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Cefcapene.

Magnesium salicylate The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Magnesium salicylate. Lorcaserin Cefotaxime may decrease the excretion rate of Lorcaserin which could result in a higher serum level. Oxyquinoline Cefotaxime may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.

Nilutamide Cefotaxime may decrease the excretion rate of Nilutamide which could result in a higher serum level. Rufinamide The therapeutic efficacy of Rufinamide can be decreased when used in combination with Cefotaxime. Cinnamaldehyde Cefotaxime may decrease the excretion rate of Cinnamaldehyde which could result in a higher serum level. Create a new account. Mangafodipir Cefotaxime may decrease the excretion rate of Mangafodipir which could result in a higher serum level.

Indometacin The risk or severity of nephrotoxicity can be increased when Indometacin is combined with Cefotaxime. Flunoxaprofen The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Flunoxaprofen. We comply with the HONcode standard for trustworthy health information – verify here.

Cefodizime Sodium

Vilanterol Cefotaxime may decrease the excretion rate of Vilanterol which could result in a higher serum level. Imidafenacin Cefotaxime may decrease the excretion rate of Imidafenacin which could result in a higher serum level.

Cefetamet The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Cefetamet. Warfarin Cefotaxime may decrease the excretion rate of Warfarin which could result in a higher serum level.

  GIUSEPPE MANUNTA PDF

Streptomycin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Streptomycin. Indapamide Cefotaxime may decrease the excretion rate of Indapamide which could result in a higher serum level. Ceftazidime Cefotaxime may decrease the excretion rate of Ceftazidime which could result in a higher serum level. Trimethadione The therapeutic efficacy of Trimethadione can be decreased when used in combination with Cefotaxime.

Capreomycin Cefotaxime may decrease the excretion rate of Capreomycin which could result in a higher serum level. Rizatriptan Cefotaxime may decrease the excretion rate of Rizatriptan which could result in a higher serum level. Gentamicin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Gentamicin. Methylnaltrexone Cefotaxime may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.

Puromycin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Puromycin. Ibutilide Cefotaxime may decrease the excretion rate of Ibutilide which could result in a higher serum level.

Temazepam Cefotaxime may decrease the excretion rate of Temazepam which could result in a higher serum level.

Cefodizime sodium | CAS | SCBT – Santa Cruz Biotechnology

Loracarbef The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Cefotaxime. Acetazolamide The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Cefotaxime. Indobufen The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Indobufen. Dichlorobenzyl alcohol Cefotaxime may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.

Anthrax immune globulin human The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Cefotaxime.